The spread of breast cancer: importance of the intrathoracic lymphatic route and its relevance to treatment. by Thomas, J. M. et al.
Br. J. Cancer (1979) 40, 540
THE SPREAD OF BREAST CANCER: IMPORTANCE OF THE
INTRATHORACIC LYMPHATIC ROUTE AND ITS RELEVANCE
TO TREATMENT
J. M. THOMAS, WV. H. REDDING AND J. P. SLOANE*
From the Royal -Marsden Hospital and Institute of Cancer Research, Sutton, Surrey
Received 14 MIay 1979 Accepted 8 Juine 1979
Summary. Detailed necropsies were performed on 26 individuals who had died of
disseminated breast carcinoma, to assess the frequency of spread to thelungs, pleura
and pericardium, and to determine the likely routes of spread to these sites. Tumour
was present in the lung parenchyma in 67% of the lungs examined, in the visceral
pleura in75%o and the parietal pleura in 5Oo0. Although even small deposits of pleural
tumour were invariably visible to naked-eye examination, lung parenchymal involve-
ment was almost invariably microscopic, despite its frequently extensive distribu-
tion. This finding draws attention to the difficulties of clinical staging with respect to
lung metastases. Tumour in lymphatics predominated over that in blood vessels in
both lung and pleura and this, together with the widespread mediastinal lymphnode
infiltration found, suggests that the lymphatic system forms the dominant route of
spread of breast carcinoma to the thorax. The possible role of mediastinal lymphatics
in the dissemination of breast cancer to bone and liver is also discussed. Our findings
suggest that the fields of adjuvant irradiation after primary surgery should include
the mediastinal lymphatic network.
IT IS COMMONLY BELIEVED that the
spread of breast cancer beyond the
regional lymph nodes is haematogenous.
However, the distinct clinical pattern of
laterality of pleural effusions in breast
cancer suggests a non-haematogenous
mechanism of dissemination. When a
pleural effusion develops for the first time
in patients with unilateral breast cancer,
it is usually on the same side as the primary
breast lesion (Stoll & Ellis, 1953; Porter,
1965). This pattern of spread would be
better explained by a regional mechanism
of dissemination, because haematogenous
tumour spread should involve both sides
ofthe thorax synchronously andwithequal
frequency.
Our previous necropsy experience had
shown that disease within lymphatics was
common at sites remote from the breast,
especially in lung and pleura. We were also
aware that visceral pleural disease was
invariably macroscopic, whilst lung paren-
chymal disease was almost invariably
microscopic. These observations prompted
us to investigate the incidence of pul-
monary and pleural metastases in breast
cancer, to determine the extent ofinvolve-
ment of various mediastinal lymphnode
groups, and to compare the frequency of
intralymphatic and intravascular (blood)
tumour. In this way further information
on the mechanism of spread of breast can-
cer to the thorax might be obtained.
MATERIALS ANI) METHODS
Detailed necropsies were performed on 26
women who had died with disseminated breast
cancer.
Breasts wiere examined by reflecting the
skin and subcutaneous tissue of the anterior
chest wall and dissecting all the breast tissue
away from the overlying skin. The breast
tissue was then cut into slices 1 cm thick
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and 4-8 blocks taken to include any macro-
scopically abnormal zones.
Lymph nodes were dissected from the fol-
lowing intrathoracic groups: (a) right and left
internal mammary, (b) right and left superior
mediastinal, (c) right and left pericardial, (d)
right and left paratracheal, (e) right and left
bronchopulmonary, and (f) posterior medias-
tinal (paraoesophageal). Groups (b) and (c)
represent nodes from the superior and inferior
portions of the anterior mediastinum respec-
tively. Both lungs were inflated with formol
saline and after 1-2 h the visceral pleural
surface was examined for evidence of meta-
stases and the lung cut into slices 1 cm thick.
The lung parenchyma was similarly examined
and blocks taken from each lung to include 2
from the periphery with overlying visceral
pleura and 2 from the neighbourhood of the
hilum to contain large bronchi and vessels. A
detailed macroscopic examination was then
made ofthe right and left parietal pleura and
pericardium and 1-3 blocks taken from each
to include any suspicious regions.
Histological examination was made on
conventional paraffin-embedded sections
stained with haematoxylin and eosin. Reti-
culin stains were also frequently used to
facilitate the identification of small vessels.
All samples of breast tissue and lymph
nodes were examined histologically. In addi-
tiontotheidentification ofinfiltrating tumour
in sections of lung parenchyma, visceral
pleura, parietal pleura and pericardium,
evidence of intralymphatic or intravascular
tumour was sought. A vessel was considered
to be lymphatic if the following criteria were
satisfied: (a) it was a thin-walled structure
without a significant muscle coat (b) it con-
tained no red blood cells and (c) in the lung,
it was present in correct anatomical location
inperivascular, peribronchial orseptalregions.
RESULTS
Bilateral breast carcinoma was diag-
nosed in 2 of the 26 patients during life.
Ofthe remaining 24, carcinoma was found
in the contralateral breast in 10 and
ranged from 0 3 to 3-0 cm in size. An intra-
duct component was demonstrated in 6
of these, and 3 were multifocal. Bilateral
breast carcinoma was therefore present
in 12 (46%) of the 26 cases. The term
ipsilateral was used to describe the side
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in which tumour was first detected and
contralateral to describe the opposite side
when bilateral breast tumour was not
detected.
In total, 286 lymphnode groups were
examined in 26 necropsies and between 1
and 12 lymph nodes were found in 242
(85%) of them. Of these, 173 (71%) con-
tained metastatic carcinoma. Nodes were
found in 106 (82%) of the 130 ipsilateral
groups and 82 (77%) of these were
involved. Of the possible 70 contralateral
groups, lymph nodes were found in 59
(84%) and 30 (51%) of these contained
metastases. Fig. 1 shows the incidence of
metastases inthe variousgroupsexamined.
Of the 52 lungs examined, visceral
pleural involvement was detected in 39
(75%) and was always macroscopically
visible, varying in appearance from occa-
sional tiny deposits less than 1 mm in
diameter to complete pulmonary encase-
ment by tumour several mm thick. Fre-
quently there was a reticulated appear-
ance, due to distention of the subpleural
lymphatic network by solid cords of
tumour (Fig. 2). Pleural effusions of
volume greater than 100 ml were present
in 55% of the cases with pleural disease.
Histological findings on visceral pleural
examination are summarized in Table
I and revealthe presence ofintralymphatic
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TABLE I.-The histological appearance of
39 visceral pleural metastatic breast
carcinomas
Histology
Intralymphatic and infiltrating
Infiltrating only
Intralymphatic, intravascular (blood)
and infiltrating
Intralymphatic only
FIG. 2.-Distension of subpleural lymphatics
by breast carcinoma. Occasional small foci
of infiltration are seen adjacent to some
of the lymphatic vessels.
tumour in 28 (72%) out of the 39 speci-
mens (Fig. 3).
The presence of intralymphatic disease
in lung, visceral or parietal pleura corre-
lated closely with the number of involved
lymphnode groups in that side ofthe medi-
astinum. In the 35 lungs with intra-
lymphatic disease in either the paren-
chyma or visceral pleura, 4 or more (of a
possible 6) lymphnode groups in that side
of the mediastinum were involved in 26
(74%) whilst 3 or less were involved in 9
(26%). Conversely, in the 12 lungs with
no metastatic disease in either paren-
chyma or visceral pleura, 4 or more
lymphnode groups in that side of the
mediastinum were involved in 4 (33%)
whilst 3 or less were involved in 8 (67%).
DISCUSSION
The present study draws attention to
the extensive infiltration of the intra-
thoracic lymphatic system by tumour
in patients who have died with dissemina-
ted breast carcinoma. This is demonstrated
by the large proportion of intrathoracic
nodal groups containing metastatic car-
cinoma and the frequency with which
lungs and pleura show easily demonstrable
evidence of intralymphatic tumour. Our
findings suggest that breast carcinoma can
spread from the ipsilateral internal mam-
mary nodes by lymphatic communications
to involve other lymph node groups on
both sides of the mediastinum, and that
lung, pleura and pericardium become
secondarily involved by lymphatic com-
munications from metastatic mediastinal
nodes. Some indication of the relative
importance of the lymphatic and haema-
togenous routes of dissemination can be
gained by comparing the frequencies
with which intralymphatic and intravas-
cular tumour was found in the various
organs examined. This varied from 2-6:1
for lung parenchyma to 7:1 for visceral
pleura and 11 :1 for parietal pleura.
This lymphatic mode of dissemination
explains the laterality of pleural effusions
in breast cancer. It would be expected
that involvement ofipsilateral mediastinal
nodes would occur sooner than contra-
lateral nodes because of the delay in
tumour embolization or permeation across
the mediastinum. Furthermore, this study
has shown that in patients with unilateral
carcinoma, lymphnode involvement was
more extensive in the ipsilateral than the
contralateral mediastinum, although the
latter did contain a substantial proportion
ofinvolved nodes. Pleural effusions due to
haematogenous metastases would be ex-
pected to occur simultaneously and with
equal frequency on each side.
No. (%)
22 (56)
11 (28)
4 (10)
2 (5)
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FIG. 3. Metastatic carcinoma within a subpleural lymphatic vessel (H. & E. x 175).
Lung parenchymal metastases were
detected in 35 (67%) of the 52 lungs
examined but were macroscopically visible
in only 4 (11%). This was partly due to
the small size of the deposits and partly
due to the fact that tumour was largely
distributed in the perivascular, peri-
bronchial and septal areas (the normal
anatomical distribution of lymphatic ves-
sels) where it blended with the connective-
tissue elements. The lack of macroscopic
detection and the relative volumes in-
volved almost certainly led to some
sampling errors, with significant under-
estimation of the incidence of lung paren-
chymal disease. Tumour was present in
lymphatics in 83% (Fig. 4) and in blood
vessels in 32% (Fig. 5) of the lungs in-
volved. The histological findings in the
lungs are summarized in Table II.
The parietal pleura of-each hemithorax
was examined separately, and metastases
were found in 26 (50%) of52 cases. Several
patterns of spread were seen. One ofthese
37
was largely postero-medial (Fig. 6) with
tumour extending from the vertebral
column in lines above and below the ribs
(Fig. 7). This presumably represents retro-
grade spread along the intercostal lym-
phatic vessels from the posterior inter-
costal nodes. Spread was rarely seen
fanning out in lines along the anterior
parietalpleurafrom the internal mammary
chain. In a number of cases, tumour was
largely confined to the lower chest wall
and diaphragm and here lymphatics
penetrating the diaphragm and draining
the liver seem to be implicated. Trans-
diaphragmatic lymphatic spread was seen
histologically in 2 cases. On histological
examination ofthe parietal pleura, tumour
was present in lymphatics in 11 (42%) and
in blood vessels in 1 (4%). The remainder
showed infiltrating tumour only.
The pericardium contained metastatic
tumour in 9 (35%) of 26 cases. Intra-
lymphatic tumour was found in 3 (33%)
cases and intravascular tumour in no
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FIG. 4. Tumour cells within a perivascular lymphatic vessel (H. & E. x 200).
TABLE II.-The histological appearance of
35 lung parenchymal metastatic breast
carcinomas
Histology
Intralymphatic and infiltrating
Intralymphatic, intravascular (blood)
and infiltrating
Intralymphatic only
Infiltrating only
Intravascular only
Intravascular and infiltrating
Intralymphatic and intravascular
No. (%)
14 (40)
7 (20)
6 (17)
4 (11)
2 (6)
0 (0)
2 (6)
cases. The remaining 6 (67%) cases showed
infiltrating tumour only.
An extensive network of communica-
tions between mediastinal lymphnode
groups both on one side and across the
mediastinum has been demonstrated by
dissection, dye-injection studies and lym-
phoscintigraphy (Rouviere, 1932; Sapin &
Borsiak, 1974; Ege, 1978). Although the in-
ternal mammarynodesnormally drain into
the bronchomediastinal trunk, lymphatic
obstruction by tumour in the upper inter-
costal spaces may redirect the lymph flow
to other lymphnode groups in the media-
stinum.
The following evidence suggests that the
direction of spread of breast carcinoma
within pulmonary lymphatics is usually
from tracheobronchial nodes centrifugally
to the lung periphery rather than vice
versa. Firstly in the 12 lungs with no
evidence of metastatic disease in either
parenchyma or visceral pleura, ipsilateral
tracheobronchial nodes contained tumour
in 7 (58%). Secondly, in the 35 (67%)
lungs which showed evidence of intra-
lymphatic disease in either parenchyma or
visceralpleura,ipsilateraltracheobronchial
nodes were found to contain tumour in 34
(97%).
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Fie. 5.-Tumour embolus within a small
pulmonary blood vessel (H. & E. x 225).
The lungs in the present study exhibited
a characteristic pattern of spread, with
macroscopic visceral pleural disease and
microscopic, predominantly intralympha-
tic, parenchymal infiltration. Haagensen
(1971) refers to this as the lymphangitic
type ofspread as distinct from the nodular
typewhich exhibits macroscopically visible
nodules of tumour infiltration and which
we saw in only 4 lungs. Although Haagen-
sen uses the term lymphangitic, he argues
that the primary spread to the lung and
pleura is haematogenous and that lym-
phatic permeation follows by extension
from blood-borne deposits. However, the
relative frequency of tumour within pul-
monaryparenchymallymphatics compared
with blood vessels in the present study
suggests that this does not occur with any
great frequency; furthermore, the foci of
infiltrating parenchymal tumour tended
to be lymphatic rather than blood vascular
in their anatomical distribution. The
clinical laterality of pleural effusions
FiG. 6.-Tumour infiltration ofparavertebral
parietal pleura.
already referred to also argues against
primary haematogenous spread. Why
metastatic breast cancer should produce
substantial tumour masses in liver, bone
and pleura and not in lung parenchyma
is unclear. Nevertheless, the predomin-
antly microscopic parenchymal disease in
breast cancer draws attention to the diffi-
culties of clinical staging with respect to
lung metastases.
It is interesting to note the high inci-
dence of bilateral breast carcinoma in this
series and its effect on the pattern of
mediastinal lymphnode metastasis. When
the contralateral breast was shown to be
free of cancer at necropsy, the overall
incidence of contralateral mediastinal
lymphnode involvement was 51%, but
when tumour was found in the contra-
lateral breast at necropsy, the contra-
lateral mediastinal lymphnode involve-
ment was 83%. The frequent presence
of an in situ component in tumours of the
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FIG. 7. Tumour nodules extending along upper and lower borders of ribs.
contralateral breast suggests that contra-
lateral mediastinal lymphatic dissemina-
tion may sometimes be from a second oc-
cult primary tumour.
The predominance of the lymphatic
route in the spread of breast cancer to the
thorax raises the question of its role in
metastasis to other organs. Handley (1 922)
described lymphatic communications be-
tween the breast and liver via the pre-
pericardial lymph nodes on the anterior
surface of the diaphragm, and standard
anatomical texts describe the lymphatic
drainage of the upper surface of the liver
to the lowermost internal mammary
nodes. The localization of bone spread to
the axial skeleton also suggests a regional
rather than a systemic mechanism of dis-
semination, but this has been explained
by communications between intercostal
veins and the paravertebral venous plexus
(Batson, 1940). It is usually stated that
breast cancer reaches the tributaries of
the intercostal veins by direct invasion,
but access could also be by lymphatico-
venous communications from metastatic
intrathoracic lymphatics.
The importance of dissemination of
breast cancer by intrathoracic lymphatics
may be relevant to the fields of adjuvant
irradiation after primary surgical treat-
ment, about which there has always been
controversy. The results of almost all
randomized trials comparing mastectomy
with mastectomy plus irradiation con-
clude thatpostoperative irradiation lowers
the incidence of local recurrence but
does not affect survival (Fisher et al.,
1970; Hamilton et al., 1974; H0st &
Breenhovd, 1975; Cancer Research Cam-
paign, 1976). In all these trials, variations
on the "3-field" technique of irradiation
have been used, in which the chest wall
and axilla are irradiated by 2 tangential
fields which are intended also to deliver a
tumoricidal dose to the ipsilateral internal
mammary nodes. The third field is a direct
anterior field to the supraclavicular nodes.
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In a recent discussion of the anatomical
variations ofthe internal mammary nodes,
Fletcher & Montague (1978) conclude that
during irradiation by the "3-field" tech-
nique, some of these nodes are either
missed completely or receive an uncertain
dose. In support of this conclusion, two
further trials have been reported recently
of mastectomy with and without post-
operative irradiation, which conclude that
survival is prolonged when the fields of
postoperative irradiation guarantee
tumoricidal doses to theinternalmammary
nodes (H0st & Breenhovd, 1977; Fletcher
& Montague, 1978). Both of these trials
used the "5-field" technique ofirradiation,
where the chest wall and axilla are treated
by two tangential fields, the supraclavicu-
lar fossa by direct anterior and posterior
fields,andtheipsilateralinternalmammary
nodes by a direct anterior field. In both
trials, the irradiation source was a 60Co
unit and the tumour dose to the internal
mammary chain was 5000 rad.
The mediastinum deep to the internal
mammary nodes would thus have been
irradiated as well and, in the average-size
patient, the ipsilateral paratracheal and
tracheobronchial nodes would have re-
ceived 3000-3500 rad. It is accepted that
size is an important determinant of res-
ponse to radiotherapy, and this moderate
dose of irradiation may be sufficient to
eliminate small lymphnode metastases
deep in the mediastinum in the early
stages of dissemination. If the hypothesis
presented in this paper is correct, the
improved survival reported by H0st &
Breenhovd (1977) could be due not only
to eradication of disease in the ipsilateral
internal mammary nodes but also to
elimination of small tumour metastases
that had already disseminated to the
ipsilateral paratracheal and tracheobron
chial nodes.
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